124 related articles for article (PubMed ID: 22034055)
1. Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice.
Thiel A; Narko K; Heinonen M; Hemmes A; Tomasetto C; Rio MC; Haglund C; Mäkelä TP; Ristimäki A
Int J Cancer; 2012 Sep; 131(5):1032-41. PubMed ID: 22034055
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
4. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effect of celecoxib in gastric cancer.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Sakamoto C
Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 and gastric carcinogenesis.
Saukkonen K; Rintahaka J; Sivula A; Buskens CJ; Van Rees BP; Rio MC; Haglund C; Van Lanschot JJ; Offerhaus GJ; Ristimaki A
APMIS; 2003 Oct; 111(10):915-25. PubMed ID: 14616542
[TBL] [Abstract][Full Text] [Related]
7. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
King VL; Trivedi DB; Gitlin JM; Loftin CD
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1137-43. PubMed ID: 16514081
[TBL] [Abstract][Full Text] [Related]
8. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
9. Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.
Yu J; Hui AY; Chu ES; Cheng AS; Go MY; Chan HL; Leung WK; Cheung KF; Ching AK; Chui YL; Chan KK; Sung JJ
Gut; 2007 Jul; 56(7):991-9. PubMed ID: 17148503
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
11. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.
Miyamoto K; Miyake S; Mizuno M; Oka N; Kusunoki S; Yamamura T
Brain; 2006 Aug; 129(Pt 8):1984-92. PubMed ID: 16835249
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
13. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
[TBL] [Abstract][Full Text] [Related]
14. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells.
Liu H; Huang P; Xu X; Liu J; Guo C
Dig Dis Sci; 2009 Jul; 54(7):1418-24. PubMed ID: 18923901
[TBL] [Abstract][Full Text] [Related]
16. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
17. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
18. [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
Ran JT; Zhou YN; Tang CW; Li HH; Li XW; Lu H
Ai Zheng; 2009 Apr; 28(4):361-5. PubMed ID: 19622294
[TBL] [Abstract][Full Text] [Related]
19. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]